HEM Pharma Inc. (KOSDAQ:376270)
South Korea
· Delayed Price · Currency is KRW 59,500
-1,500 (-2.46%)
At close: Apr 28, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 426.98 billion as of April 28, 2026. Its market cap has increased by 165.50% in one year.
Market Cap
426.98B
Enterprise Value
432.68B
Revenue
12.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
59,500.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 426.98B, an increase of 273.96%. That is a compound annual growth rate of 144.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 437.75B | 33.67% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 479.90B |
| ImmuneOncia Therapeutics | 536.91B |
| Samyang Biopharm | 591.90B |
| DAE HWA Pharmaceutical | 265.38B |
| NOVAREX | 264.12B |
| GREEN CROSS WellBeing | 257.84B |
| Myung In Pharmaceutical LTD. | 838.04B |
| High Tech Pharm | 211.60B |